Dr. Breelyn A. Wilky, MD., Assistant Professor – Sarcoma Program, Sylvester Comprehensive Cancer Center from the Division of Hematology/Oncology Leonard M. Miller School of Medicine at the University of Miami has organized an ASPS open day of learning.
The open day will take place on Friday, September 23, 2016 7:30am-5:00pm. The event is open to patients, families, and researchers who want to attend. Please see below the details.
If you wish to attend please RSVP to Krystin Altieri (firstname.lastname@example.org).
Location: University of Miami Life Science & Technology Park,1951 NW 7th Avenue, 1st Floor, Miami, FL 33136
|7:30–8:00 am||Registration & Breakfast|
|8:00–8:15 am||Breelyn Wilky, M.D.
Director, Sylvester Comprehensive Cancer Center
|8:15–8:30 am||Christie Martell
The Manny Alvarez Foundation
|8:30–9:00 am||Breelyn Wilky, M.D.Sylvester Comprehensive Cancer Center||Overview of Alveolar Soft Part Sarcoma: Past, Present, and Future|
|9:00–9:30 am||Andrew Rosenberg, M.D.Sylvester Comprehensive Cancer Center||Pathology and Molecular Aberrations in ASPS|
|9:30–10:00 am||Fran Hornicek, M.D. Mass General||The Role of Surgery in ASPS|
|10:00–10:15 am||Nathan Traller4Nathalie Foundation||Patient Perspectives on Finding Treatments for ASPS|
|10:15–10:30 am||Coffee Break|
|10:30–11:00 am||Robert Meehan, M.D.National Institute of Health||Cediranib and other TKI for ASPS patients – the US perspective and future directions|
|11:00–11:30 am||Ian Judson Royal Marsden, M.D.||ASPS in Europe|
|11:30–12:00 pm||Paul Chen Advenchen Pharmaceuticals||Anlotinib for STS|
|12:00–1:00 pm||Lunch / Patient Q&A|
|1:00–1:30 pm||Neeta Somaiah, M.D.MD Anderson Cancer Center||Immunotherapy for ASPS patients|
|1:30–2:00 pm||David Hong, M.D.MD Anderson Cancer Center||Next generation of immunotherapies for ASPS & perspectives on conducting Phase I trials for rare tumors|
|2:00–2:30 pm||John Goldberg, M.D.Agenus Biotech||Vaccine therapy for ASPS patients|
|2:30–2:45 pm||Coffee Break|
|2:45–3:15 pm||Charles Keller, M.D.Children’s Cancer Therapy Development Institute||Preclinical drug screens and target validation|
|3:15–3:45 pm||Kevin Jones, M.D.Huntsman Cancer Institute||Mouse models of ASPS and targeting metabolism|
|3:45–4:15 pm||Andrew Wagner, M.D., Ph.D.Dana-Farber Cancer Institute||Targeting CMET in ASPS|
|4:15–4:45 pm||Yosef Landesman, Ph.D.President of Cure ASPS International, Karyopharm||Novel targets in ASPS drug development|
|4:45–5:00 pm||Stephen D. Nimer, M.D.Director, Sylvester Comprehensive Cancer Center||Closing Remarks|
Yosef Landesman, Ph.D.
President & Cancer Research Director
Cure Alveolar Soft Part Sarcoma International (iCureASPS)